August 6, 2015 | The Israeli tissue repair company LifeBond announced that it raised $27 million in Series D funding. Investors in the round include Pitango Venture Capital, Adams Street Partners, Sino Biopharmaceutical, as well as existing investors. LifeBond, which has raised $60 million in funding to date, was founded in 2007 by Ishay Attar and Orahn Preiss-Bloom. The company is based in Caesaria, Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Pineapple-Based Burn Therapy Treating Injured US Troops
October 02, 2023

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Facebook comments